|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows Provided By (Used In) Operating Activities: | |||||
| Net Income (Loss) | |||||
| Adjustments to reconcile net income (loss) to net cash and cash equivalents and cash collateral posted to counterparties provided by operating activities: | |||||
| Net (accretion) amortization of premium (discount) on Agency Securities | |||||
| Net amortization of U.S. Treasury Securities | |||||
| U.S. Treasury Securities | |||||
| Realized loss on sale of Agency Securities, available for sale | |||||
| Impairment losses on available for sale Agency Securities | |||||
| (Gain) Loss on Agency Securities, trading, net | |||||
| (Gain) Loss on U.S. Treasury Securities, net | |||||
| U.S. Treasury Securities | |||||
| Stock based compensation | |||||
| Changes in operating assets and liabilities: | |||||
| Increase in accrued interest receivable | |||||
| (Increase) decrease in prepaid and other assets | |||||
| Change in derivatives, at fair value | |||||
| Increase in accrued interest payable- repurchase agreements | |||||
| (Decrease) increase in accrued interest payable- U.S. Treasury Securities sold short | |||||
| (Decrease) increase in accounts payable and other accrued expenses | |||||
| Net cash and cash equivalents and cash collateral posted to counterparties provided by operating activities | |||||
| Cash Flows Provided By (Used In) Investing Activities: | |||||
| Purchases of Agency Securities (including $0, $0 and $57,039 with BUCKLER, respectively) | |||||
| Purchases of U.S. Treasury Securities (including $454,164, $0 and $155,857 with BUCKLER, respectively) | |||||
| U.S. Treasury Securities | |||||
| Principal repayments of Agency Securities | |||||
| Proceeds from sales of Agency Securities | |||||
| Proceeds from sales of U.S. Treasury Securities (including $100,502, $0 and $154,875 with BUCKLER, respectively) | |||||
| U.S. Treasury Securities | |||||
| Disbursements on reverse repurchase agreements (including $(1,860,188), $(4,643,450) and $(2,774,490), respectively with BUCKLER) | |||||
| Total disbursements on reverse repurchase agreements (including $(1,860,188), $(4,643,450) and $(2,774,490), respectively with BUCKLER) | |||||
| Receipts from reverse repurchase agreements (including $2,307,250, $4,550,325 and $3,124,829, respectively with BUCKLER) | |||||
| Total receipts from reverse repurchase agreements (including $2,307,250, $4,550,325 and $3,124,829, respectively with BUCKLER) | |||||
| Increase (decrease) in cash collateral posted by counterparties | |||||
| Proceeds from subordinated loan due to BUCKLER | |||||
| Net cash and cash equivalents and cash collateral posted to counterparties used in investing activities | |||||
| Cash Flows Provided By (Used In) Financing Activities: | |||||
| Issuance of Series C Preferred stock, net of expenses | |||||
| Series C Preferred Stock | |||||
| Issuance of common stock, net of expenses | |||||
| Proceeds from repurchase agreements (including $89,783,916, $59,055,222 and $69,806,936, respectively with BUCKLER) | |||||
| Total proceeds from repurchase agreements (including $89,783,916, $59,055,222 and $69,806,936, respectively with BUCKLER) | |||||
| Principal repayments on repurchase agreements (including $(86,699,441), $(58,734,577) and $(68,737,266), respectively with BUCKLER) | |||||
| Total principal repayments on repurchase agreements (including $(86,699,441), $(58,734,577) and $(68,737,266), respectively with BUCKLER) | |||||
| Common stock dividends paid | |||||
| Common stock repurchased, net | |||||
| Net cash and cash equivalents and cash collateral posted to counterparties provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents and cash collateral posted to counterparties | |||||
| Cash and cash equivalents and cash collateral posted to counterparties - beginning of year | |||||
| Cash and cash equivalents and cash collateral posted to counterparties - end of year | |||||
| Supplemental Disclosure: | |||||
| Cash paid during the year for interest | |||||
| Payable for unsettled purchases | |||||
| Non-Cash Investing Activities: | |||||
| Payable for unsettled purchases | |||||
| Net unrealized gain (loss) on available for sale Agency Securities | |||||
| Non-Cash Financing Activities: | |||||
| Amounts receivable for issuance of preferred stock | |||||
Loading...